Jennifer Dubas
Compliance Officer presso CENCORA, INC.
Profilo
Jennifer E.
Dubas is currently the Chief Compliance Officer & Senior Vice President at Cencora, Inc. She previously worked as In-House Counsel at Wyeth LLC and Pfizer Inc. and as Vice President & Chief Compliance Officer at Endo International Plc.
Ms. Dubas received her undergraduate degree from Bryn Mawr College and her graduate degree from Temple University Beasley School of Law.
Posizioni attive di Jennifer Dubas
Società | Posizione | Inizio |
---|---|---|
CENCORA, INC. | Compliance Officer | 01/09/2022 |
Precedenti posizioni note di Jennifer Dubas
Società | Posizione | Fine |
---|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
PFIZER, INC. | Corporate Officer/Principal | - |
ENDO INTERNATIONAL PLC | Compliance Officer | - |
Formazione di Jennifer Dubas
Bryn Mawr College | Undergraduate Degree |
Temple University Beasley School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PFIZER, INC. | Health Technology |
CENCORA, INC. | Distribution Services |
Aziende private | 2 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Dubas